|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1986-6-9
|
|
pubmed:abstractText |
Forty nulliparous women were treated with vaginal suppositories containing Meteneprost (9-deoxo-16, 16-dimethyl-9-methylene PGE2) (Upjohn Co.) 10 mg or placebo prior to termination of first trimester pregnancy in a double-blind study. The suppository was inserted three hours before vacuum aspiration. The cervical diameter as measured by the size of the largest Hegar dilatator inserted without resistance was significantly larger in women treated with Meteneprost. The operative blood loss was also reduced in the Meteneprost group.
|
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Abortion, Induced,
http://linkedlifedata.com/resource/pubmed/keyword/Biology,
http://linkedlifedata.com/resource/pubmed/keyword/Cervix,
http://linkedlifedata.com/resource/pubmed/keyword/Endocrine System,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/Fertility Control, Postconception,
http://linkedlifedata.com/resource/pubmed/keyword/Genitalia,
http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female,
http://linkedlifedata.com/resource/pubmed/keyword/PROSTAGLANDINS,
http://linkedlifedata.com/resource/pubmed/keyword/Physiology,
http://linkedlifedata.com/resource/pubmed/keyword/Preoperative Procedures,
http://linkedlifedata.com/resource/pubmed/keyword/Prostaglandins, Synthetic,
http://linkedlifedata.com/resource/pubmed/keyword/Surgery,
http://linkedlifedata.com/resource/pubmed/keyword/Treatment,
http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System,
http://linkedlifedata.com/resource/pubmed/keyword/Uterus,
http://linkedlifedata.com/resource/pubmed/keyword/Vacuum Aspiration
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0010-7824
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
189-94
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3698595-16,16-Dimethylprostaglandin E2,
pubmed-meshheading:3698595-Abortifacient Agents,
pubmed-meshheading:3698595-Abortifacient Agents, Nonsteroidal,
pubmed-meshheading:3698595-Abortion, Induced,
pubmed-meshheading:3698595-Adult,
pubmed-meshheading:3698595-Cervix Uteri,
pubmed-meshheading:3698595-Double-Blind Method,
pubmed-meshheading:3698595-Female,
pubmed-meshheading:3698595-Humans,
pubmed-meshheading:3698595-Pregnancy,
pubmed-meshheading:3698595-Pregnancy Trimester, First,
pubmed-meshheading:3698595-Prostaglandins E, Synthetic,
pubmed-meshheading:3698595-Random Allocation,
pubmed-meshheading:3698595-Suppositories,
pubmed-meshheading:3698595-Uterine Hemorrhage,
pubmed-meshheading:3698595-Vacuum Curettage,
pubmed-meshheading:3698595-Vomiting
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
